维普中文期刊产品整合服务
76篇 您的检索式:作者名="Kaniwa"
    题名 作者 年代 出处 被引量
1Assessment of gastric acidity of Japanese subjects over the last 15 years 显示文摘MORIHARA M AOYAGI N KANIWA N 2001Biol Pharm Bull2001,24,3:1
2Prediction of severe adversedrug reactions using pharmacogenetic biomarkers显示文摘Tohkin M Ishiguro A Kaniwa N 2010Drug MetabPharmacokinet2010,25,:1
3HLA-B locus in Japane- sepatients with antiepileptics and allopurinol-related Ste- vens- Johnson syndrome and toxic epidermal necrolysis显示文摘Kaniwa N Saito Y Aihara M 2008Phamlacogenomics2008,9,11:1
4Determination of p-phenylenediamine and related antioxidants in rubber boots by high performance liquid ehromatography显示文摘Ikarashi Y Kaniwa M 2000Journal of Health Science2000,46,6:1
5Gastric acidity dependent bioavailability of cinnarizine from two commercial capsules in healthy volunteers 显示文摘OGATA H AOYAGI N KANIWA N 1986lnt J Pharm1986,29,2:1
6Homozygous CDA*3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patients显示文摘Ueno H Kaniwa N Okusaka T 2009Br J Cancer2009,100,6:1
7HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients显示文摘KANIWA N SAITO Y AIHARA M et ol 2010Epilepsia2010,51,12:1
8Racial variability in haplotype frequencies of UGT1A1 and glucuronidation activity of a novel single nucleotide polymorphism 686C> T(P229L)found in an African-American 显示文摘Kaniwa N Kurose K Jinno H 2005Drug Metab Dispos2005,33,3:1
9Haplotype analysis of ABCBI/MDRI blocks in a Japanese population reveals genotype-dapendent renal clearance of irinotecan显示文摘Sai K Kaniwa N 2003Pharmacogenetics2003,13,12:1
10HLA-B locus in Japanese patients with anti-epileptics and allo- purinol-related Stevens-Johnson syndrome and tox- ic epidermal necrolysis 显示文摘Kaniwa N Saito Y Aihara M 2008Pharmacogenomics2008,9,11:1
11Racial variability in haplotype frequencies of UGT1A1 and glucuronidation activity of a novel single nucleotide polymorphism 686C > T(P229l) found in an African-American显示文摘Kaniwa N Kurose K Jinno H 2005Drug Metab Dispos2005,33,3:1
12Impact of CYP3A4 haplotypes on irinotecan pharmacokinetics in Japanese cancer patients显示文摘Kimie Sai Yoshiro Saito Hiromi Fukushima-Uesaka Koichi Kurose Nahoko Kaniwa Naoyuki Kamatani Kuniaki Shirao Noboru Yamamoto Tetsuya Hamaguchi Hideo Kunitoh Yuichiro Ohe Tomohide Tamura Yasuhide Yamada Hironobu Minami Atsushi Ohtsu Teruhiko Yoshida Nagahir 2008Cancer Chemotherapy and Pharmacology2008,,3:1
13A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients显示文摘Tohkin M Kaniwa N Saito Y 2013Pharmacogenomics J2013,13,1:1
14HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related stevens-johnson syndrome and toxic epidermal necrolysis显示文摘Kaniwa N Saito Y Aihara M 2008Pharmacogenomics2008,9,11:1
15Population pharmacokinetics of gemcitabine and its metabolite in Japanese cancer patients:impact of genetic polymorphisms显示文摘Sugiyama E Kaniwa N Kim SR 2010Clin Pharmacokinet2010,49,8:1
16Development of a rapid and inexpensive assay for detecting a surrogate genetic polymorphism of HLA-B*58:01: a partially predictive but useful biomarker for allopurinol-related Stevens-Johnson syndrome/toxic epidermal necrolysis in Japanese显示文摘Maekawa K Nishikawa J Kaniwa N 2012Drug Metab Pharmacokinet2012,27,4:1
17HLA- B locus in Japanese patients with antiepileptics and altopurinol -related Stevens -Johnson syndrome and toxic epidermal necrolysis 显示文摘Kaniwa N Saito Y Aihara M 2008Pharmacogenomics2008,9,11:1
18HLA-B locus in Japanesepatients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis显示文摘Kaniwa N Saito Y Aihara M 2008Pharma-cogenomics2008,9,11:1
19Racial variability in haplotype frequencies of UGT1 A1 and glucuronidation activity of a novel single nucleotide polymorphism 686C > T(P229L) found in an African-American显示文摘Kaniwa N Kurose K Jinno H 2005Drug Metab Dispos2005,33,3:1
20Pharmaeokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism 显示文摘Sugiyama E Kaniwa N Kim SR 2007J Clin Oncol2007,25,1:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费